SINGAPORE (Oct 16): Trendlines Medical Singapore, a 76.43%-owned subsidiary of Catalist-listed Israeli company The Trendlines Group, has made its first investment by committing a total of US$60,000 (S$81,150) to a medical device start-up, InterVaal.
InterVaal is developing a urological catheter to address catheter-associated urinary tract infection.
Trendlines says that its in-house innovation unit, Trendlines Labs, will work with...(click on link for full story on theedgesingapore.com)